Teva Homepage Print this page Site Map
About TevaInvestor RelationsTeva Worldwide

Press Release

Teva To Present At The 28th Annual J.P. Morgan Healthcare Conference

Jerusalem, Israel, January 8, 2010 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) will host a live audio webcast at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Eyal Desheh, Chief Financial Officer and William Marth, President and CEO, Teva North America, will present on Monday, January 11, 2010.

What: Teva Presentation at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Who: Eyal Desheh, Chief Financial Officer
William Marth, President and CEO, Teva North America

When: Monday, January 11, 2010 at 1:30 p.m. (PST)

Where: www.tevapharm.com or http://metameetings.com/webcasts/jpmorgan/healthcare10/directlink/?ticker=TEVA

How: Live over the Internet - log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.

About Teva
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.



Company Contacts:

Elana Holzman
Teva Pharmaceutical Industries, Ltd.
972 (3) 926-7554

Kevin Mannix
Teva North America
(215) 591-8912